{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:17:00Z","timestamp":1768637820288,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jdin.2024.09.015","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:43:03Z","timestamp":1731584583000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Optimizing the management of psoriasis in patients with skin of color: A\u00a0Canadian Delphi consensus"],"prefix":"10.1016","volume":"19","author":[{"given":"Geeta","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette","family":"Miller-Monthrope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaggi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel N.","family":"Asiniwasis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parbeer","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles W.","family":"Lynde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Metelitsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loukia","family":"Mitsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boluwaji","family":"Ogunyemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri S.","family":"Purdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell","family":"Sauder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jensen","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jdin.2024.09.015_bib1","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2022.5270","article-title":"Psoriasis","volume":"327","author":"Walter","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jdin.2024.09.015_bib2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1365-4632.2011.05359.x","article-title":"Economic burden of moderate to severe plaque psoriasis in Canada","volume":"51","author":"Levy","year":"2012","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2024.09.015_bib3","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s13555-022-00811-0","article-title":"Unmet need in people with psoriasis and skin of color in Canada and the United States","volume":"12","author":"Yadav","year":"2022","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jdin.2024.09.015_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00403-022-02324-4","article-title":"Racial\/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review","volume":"315","author":"Ferguson","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"10.1016\/j.jdin.2024.09.015_bib5","first-page":"20","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.09.015_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.36849\/JDD.7090","article-title":"Evolving concepts in psoriasis: special considerations for patients with skin of color, skin barrier dysfunction, and the role of adjunctive skin care","volume":"21","author":"Alexis","year":"2022","journal-title":"J Drugs Dermatol"},{"issue":"2S","key":"10.1016\/j.jdin.2024.09.015_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.12788\/cutis.0038","article-title":"Psoriasis in patients of color: differences in morphology, clinical presentation, and treatment","volume":"106","author":"Nicholas","year":"2020","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.jdin.2024.09.015_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40257-017-0332-7","article-title":"Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-white racial\/ethnic groups","volume":"19","author":"Kaufman","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2024.09.015_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaad.2021.01.022","article-title":"A cross-sectional study of Latino patients screened for psoriasis clinical trials at the University of California-Irvine","volume":"85","author":"Ashbaugh","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.09.015_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaad.2017.02.042","article-title":"Ethnicity affects the presenting severity of psoriasis","volume":"77","author":"Abrouk","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.09.015_bib11","first-page":"650","article-title":"Racial and ethnic disparities in access to emerging and frontline therapies in common dermatological conditions: a cross-sectional study","volume":"112","author":"Bell","year":"2020","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"10.1016\/j.jdin.2024.09.015_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.1967.01610010045004","article-title":"Psoriasis in Kenya","volume":"96","author":"Verhagen","year":"1967","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.09.015_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1346-8138.2011.01400.x","article-title":"Clinical characteristics of childhood psoriasis in a multi-ethnic Asian population","volume":"39","author":"Chandran","year":"2012","journal-title":"J Dermatol"},{"issue":"11","key":"10.1016\/j.jdin.2024.09.015_bib15","first-page":"16","article-title":"Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances","volume":"7","author":"Alexis","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jdin.2024.09.015_bib16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s40615-022-01282-x","article-title":"Exploring biologic treatment hesitancy among black and indigenous populations in Canada: a review","volume":"10","author":"Akuffo-Addo","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"issue":"1","key":"10.1016\/j.jdin.2024.09.015_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjd.19876","article-title":"Biologics utilization for psoriasis is lower in black compared with white patients","volume":"185","author":"Hodges","year":"2021","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jdin.2024.09.015_bib18","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jid.2018.12.032","article-title":"Racial differences in perceptions of psoriasis therapies: implications for racial disparities in psoriasis treatment","volume":"139","author":"Takeshita","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.09.015_bib19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/09546634.2019.1687824","article-title":"Differences in healthcare barriers based on racial and\/or ethnic background for patients with psoriasis","volume":"32","author":"Bray","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"10.1016\/j.jdin.2024.09.015_bib20","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1080\/09546634.2022.2114783","article-title":"Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review","volume":"33","author":"Sevagamoorthy","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jdin.2024.09.015_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamadermatol.2021.5596","article-title":"Assessment of changes in diversity in dermatology clinical trials between 2010-2015 and 2015-2020: a systematic review","volume":"158","author":"Chen","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.09.015_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/ced.14871","article-title":"Racial representation in clinical trials for dermatological new molecular entities","volume":"47","author":"Ha","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"16","key":"10.1016\/j.jdin.2024.09.015_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12874-016-0165-8","article-title":"Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology","volume":"20","author":"Eubank","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jdin.2024.09.015_bib25","article-title":"Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement","author":"Alexis","year":"2024","journal-title":"JAMA Dermatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724001731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724001731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T17:56:48Z","timestamp":1744999008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328724001731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":23,"alternative-id":["S2666328724001731"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2024.09.015","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the management of psoriasis in patients with skin of color: A\u00a0Canadian Delphi consensus","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2024.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}